Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has received final approval by the United States Food & Drug Administration (FDA) for topiramate capsules USP, ...

The agreement is to acquire topiramate HCl 25, 50, 100 and 200 mg tablets for an undisclosed amount. Topiramate is indicated as a treatment of epilepsy and migraine and its market size in the USA was ...

Topiramate 25-mg tablets were used in whole or part, up to doses of 100 mg/day. On reaching this dose, patients then used 50-mg tablets twice daily. All subjects were required to contact the ...

Topiramate (Topamax) 25 mg once daily, titrated to 300 mg/day in two divided doses for 14 weeks, was evaluated in a placebo-controlled randomized trial in 371 patients aged 18-65 years with ...

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Monday its topiramate tablets in 50 mg form have been granted tentative approval from the Food and Drug Administration.